http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1313164-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe9b2c6cd12d21589455e1c85cc48051 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K23-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 |
| filingDate | 1970-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1973-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1313164-A |
| titleOfInvention | Blood plasma substitute |
| abstract | 1313164 Blood plasma substitutes KNOX GELATINE INC 28 April 1970 [28 April 1969] 20279/70 Heading ASB [Also in Division C3] A blood plasma substitute comprises an aqueous solution of: 0.5 to 6% of gelatin or gelatin derived compound; a non-toxic acetate, citrate, gluconate or lactate in an amount capable of generating in vivo 20 to 60 mEq of bicarbonate ions in body fluids for each litre of solution administered; and sodium, potassium and chloride ions in physiological concentration. Modified fluid gelatin, the reaction product of gelatin of average M.W. 15,000-36,000 with succinic anhydride, oxypolygelatin, and polypeptides coupled with diisocyanate are examples of gelatin derived compounds. The blood plasma substitute preferably contains 135-155 mEq sodium ions, 3-5 mEq potassium ions, 90-110 mEq chloride ions, 2-4 mEq magnesium ions and 3-5 mEq calcium ions per litre. An example discloses blood plasma substitutes comprised of one of the above gelatin-derived compounds, sodium chloride, potassium chloride, magnesium chloride, sodium lactate, glucose or fructose (optional) and distilled water. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865397-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6410218-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102007047040-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6444418-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6080538-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6387612-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6406839-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3138094-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102470147-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011009797-A3 |
| priorityDate | 1969-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.